A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults

NCT05523596 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues

Interventions

DRUG: ICM20
DRUG: Benznidazole

Sponsor

IC-MedTech Corporation